Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China
· Delayed Price · Currency is CNY 50.90
+0.01 (0.02%)
Apr 29, 2026, 3:00 PM CST
SHA:688050 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | 237.31 | 240.59 | 388.4 | 303.98 | 232.69 | 171.34 | Upgrade
|
| Depreciation & Amortization | 168.71 | 168.71 | 132.89 | 76.73 | 43.35 | 32.04 | Upgrade
|
| Other Amortization | 11.1 | 11.1 | 13.37 | 9.73 | 9.08 | 7.33 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.09 | 0.09 | -0.02 | -0.11 | -0.01 | -0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | 87.22 | 87.22 | 2.08 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.62 | -4.62 | 0.69 | -11.7 | -18.58 | -19.59 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 10.9 | 9.13 | 8.37 | 5.74 | Upgrade
|
| Other Operating Activities | -19.31 | 34.21 | 22.06 | -9.64 | -3.07 | -1.91 | Upgrade
|
| Change in Accounts Receivable | -129.39 | -129.39 | -127.09 | -103.52 | -45.76 | 1.12 | Upgrade
|
| Change in Inventory | -72.53 | -72.53 | -86.09 | -85.12 | -22.82 | 3.35 | Upgrade
|
| Change in Accounts Payable | 50.92 | 50.92 | 7.15 | 21.46 | 21.41 | 15.07 | Upgrade
|
| Change in Other Net Operating Assets | 2.02 | 2.02 | 6.11 | 12.39 | 17.56 | 13.25 | Upgrade
|
| Operating Cash Flow | 312.35 | 369.15 | 347.75 | 212.62 | 250.13 | 219.3 | Upgrade
|
| Operating Cash Flow Growth | -15.42% | 6.15% | 63.56% | -15.00% | 14.06% | 77.78% | Upgrade
|
| Capital Expenditures | -97.97 | -123.14 | -329.48 | -370.34 | -271.03 | -311.22 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.34 | 0.03 | 0.01 | 0.43 | 0.04 | - | Upgrade
|
| Cash Acquisitions | -696.07 | -30.33 | -72.3 | -47.03 | - | - | Upgrade
|
| Divestitures | 2.3 | 2.3 | - | - | - | - | Upgrade
|
| Investment in Securities | 169.68 | -2.58 | -213.06 | 439.64 | -51.29 | -120.9 | Upgrade
|
| Other Investing Activities | 4.72 | 9.75 | 1.06 | 15.97 | 21.44 | 19.75 | Upgrade
|
| Investing Cash Flow | -617 | -143.96 | -613.76 | 32.67 | -307.84 | -420.37 | Upgrade
|
| Long-Term Debt Issued | - | 35 | 481.62 | 12.16 | 10 | 143.37 | Upgrade
|
| Long-Term Debt Repaid | - | -57.77 | -299.86 | -19.43 | -5.4 | - | Upgrade
|
| Net Debt Issued (Repaid) | 563.03 | -22.77 | 181.75 | -7.27 | 4.6 | 143.37 | Upgrade
|
| Issuance of Common Stock | 287.71 | 287.71 | 3.97 | 13.48 | 1.56 | 24.91 | Upgrade
|
| Repurchase of Common Stock | - | - | -20.04 | - | - | - | Upgrade
|
| Common Dividends Paid | -88.73 | -89.46 | -70.56 | -61.37 | -44.44 | -30.52 | Upgrade
|
| Other Financing Activities | -139.68 | -132.9 | 2.99 | -8.41 | -26.79 | -0.02 | Upgrade
|
| Financing Cash Flow | 622.33 | 42.58 | 98.12 | -63.57 | -65.07 | 137.74 | Upgrade
|
| Foreign Exchange Rate Adjustments | -3.31 | -1.86 | -0.02 | 0.04 | -0.04 | -0.64 | Upgrade
|
| Net Cash Flow | 314.37 | 265.91 | -167.91 | 181.76 | -122.82 | -63.97 | Upgrade
|
| Free Cash Flow | 214.39 | 246.01 | 18.27 | -157.72 | -20.9 | -91.92 | Upgrade
|
| Free Cash Flow Growth | 95.85% | 1246.45% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 14.07% | 16.59% | 1.30% | -16.58% | -3.61% | -21.22% | Upgrade
|
| Free Cash Flow Per Share | 1.11 | 1.28 | 0.10 | -0.83 | -0.11 | -0.49 | Upgrade
|
| Cash Income Tax Paid | 161.38 | 161.48 | 157.99 | 157.93 | 58.75 | 57.3 | Upgrade
|
| Levered Free Cash Flow | -50.15 | 120.09 | -182.09 | -215.88 | -110.16 | -105.6 | Upgrade
|
| Unlevered Free Cash Flow | -50.15 | 120.09 | -169.14 | -209.74 | -108.89 | -105.14 | Upgrade
|
| Change in Working Capital | -168.15 | -168.15 | -222.61 | -165.5 | -21.71 | 24.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.